We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CATO: REPEALING IMPORTATION BAN WOULD ENCOURAGE R&D EQUITY
CATO: REPEALING IMPORTATION BAN WOULD ENCOURAGE R&D EQUITY
August 5, 2004
A senior scholar at the libertarian Cato Institute recommends that the U.S. repeal its ban on the importation of Rx drugs and allow pharmaceutical companies and foreign countries to work out on their own what the latter will pay for U.S. patented medicines.